Nanjing Vcare PharmaTech Co., Ltd. (hereinafter referred to as "Nanjing Vcare") is a wholly owned subsidiary split and established by Jiangsu Vcare PharmaTech Co., Ltd. (hereinafter referred to as "Jiangsu Vcare") in 2021 to independently operate the CRO/CDMO sector business.

Nanjing Vcare focuses on the whole industrial chain and lifecycle R & D and manufacturing services of chemical drugs with an international perspective, makes every effort to build Chemistry+Pharmacy+Medicine One-stop CRO/CDMO service platform, accelerates and empowers the R & D of drugs, and is committed to providing CMC, clinical and registration (CRO) services for new and generic drugs, contract development and manufacturing (CDMO) services for new drugs, manufacturing and sales of characteristic API, advanced intermediates and impurities.